Developmental exposure to lead and late life abnormalities of nervous system

Indian Journal of Experimental Biology

Volumn 48, Issue 7, 2010, Pages 636-641

  Basha, Riyaz ^a   Rajarami, G Reddy ^b  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

Developmental exposure; Environmental exposure; Epigenetics; Lead; Neurodegeneration

Indexed keywords

LEAD;

ADULT; AGING; ALZHEIMER DISEASE; DRUG EFFECT; ENVIRONMENT; GROWTH, DEVELOPMENT AND AGING; HUMAN; LEAD POISONING; NERVOUS SYSTEM; PATHOLOGY; REVIEW; DRUG EFFECTS;

ADULT; AGING; ALZHEIMER DISEASE; ENVIRONMENT; GROWTH AND DEVELOPMENT; HUMANS; LEAD; LEAD POISONING, NERVOUS SYSTEM; NERVOUS SYSTEM;

MURINAE; PRIMATES;

EID: 77954302476     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Barker D J, Winter P D, Osmond C, Margetts B & Simmonds S J, Weight in infancy and death from ischaemic heart disease, Lancet, 2 (1989) 577.
2. Barker D J, Fetal origins of cardiovascular disease, Ann Med Supl, 1 (1999) 3.
3. Barker D J, Fetal programming of coronary heart disease, Trends Endocrinol Metab, 13 (2002) 364.
4. Barker D J, Developmental origins of adult health and disease, J Epidemiol Community Health, 58 (2004) 114.
5. Valdez R, Athens M A, Thompson G H, Bradshaw B S & Stern M P, Birth weight and adult health outcomes in a biethnic population in the USA, Diabetologia, 37 (1994) 624.
6. Yarbrough D E, Barrett-Connor E, Kritz-Silverstein D & Wingard D L, Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo Study, Diabetes Care, 21 (1998) 1652.
7. Boksa P & El-Khodor B F, Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders, Neurosci Biobehav Rev, 27 (2003) 91.
8. Dalman C, Allebeck P, Cullberg J, Grunewald C & Koster, M, Obstetric complications and the risk of schizophrenia: A longitudinal study of a national birth cohort, Arch Gen Psychiatry, 56 (1999) 234.
9. Preti A, Fetal hypoxia, genetic risk, and schizophrenia, Am J Psychiatry, 160(2003) 1186.
10. Bilbo S D, Levkoff L H, Mahoney J H, Watkins L R, Rudy J W & Maier S F, Neonatal infection induces memory impairments following an immune challenge in adulthood, Behav Neurosci, 119 (2005) 293.
11. Rice D, Delayed neurotoxicity in monkeys exposed developmentally to methyl mercury, Neurotoxicology, 10 (1989)645.
12. Lee M H & Rabe A, Premature decline in Morris water maze performance of aging micrencephalic rats, Neurotoxicol Teratol, 14 (1992) 383.
13. Barone Jr S, Stanton M E & Mundy W R, Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging, Neurobiol Aging, 16 (1995) 723.
14. Thiruchelvam M, Richfield E K, Goodman B M, Baggs R B & Cory-Slechta D A, Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype, Neurotoxicology, 23 (2002) 621.
15. Reeves R, Thiruchelvam M, Richfield E K & Cory-Slechta D A, Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon, Pharmacol Biochem Behav, 76 (2003) 315.
16. Basha M R, Wei W, Bakheet S A, Benitez N, Siddiqi H K, Ge Y W & Zawia N H, The fetal basis of amyloidogenesis: Exposure to lead and latent overexpression of amyloid precursor protein and betaamyloid in the aging brain,/Neurosci, 25 (2005) 823.
17. White L D, Cory-Slechta D A, Gilbert M E, Tiffany-Castiglioni E, Zawia N H, Virgolini M, Rossi-George A, Lasley S M, Qian Y C & Basha M R, New and evolving concepts in the neurotoxicology of lead, Toxicol Appl Pharmacol, 225 (2007) 1.
18. Goyer R A, Toxic effects of metals, in Casarett and Doull's toxicology: the basic science of poisons, edited by C D Klaassan (McGraw-Hill, New York) 1996, 691.
19. Needleman H L, Schell A, Bellinger D, Leviton A & Allred E N, The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report, N Engl J Med, 322 (1990) 83.
20. Silbergeld E K, Mechanisms of lead neurotoxicity, or looking beyond the lamppost, FASEB J, 6 (1992) 3201.
21. Zawia N H, Transcriptional involvement in neurotoxicity, Toxicol Appl Pharmacol, 190 (2003) 177.
22. Basha M R, Wei W, Brydie M, Razmiafshari M & Zawia N H, Leadinduced developmental perturbations in hippocampal Spl DNA-binding are prevented by zinc supplementation: in vivo evidence for Pb and Zn competition, Int J Dev Neurosci, 21 (2003) 1.
23. Atkins D S, Basha M R & Zawia N H, Intracellular signaling pathways involved in mediating the effects of lead on the transcription factor Spl, Int J Dev Neurosci, 21 (2003) 235.
24. Basha M R, Wei W, Reddy G R & Zawia N H, Zinc finger transcription factors mediates perturbations of brain gene expression elicited by heavy metals, in Molecular neurotoxicology, environmental agents, and transcription-transduction coupling, edited by N H Zawia (CRC Press, Boca Raton, FL) 2004, 43.
25. Reddy G R, Devi C B & Chetty C S, Developmental lead neurotoxicity: Alterations in brain cholinergic system, Neurotoxicology, 28 (2007) 402.
26. Bakheet S A, Basha M R, Cai H & Zawia N H, Lead exposure: Expression and activity levels of Oct-2 in the developing rat brain, Toxicol Sci, 95 (2007) 436.
27. Lidsky, T I & Schneider, J S, Lead neurotoxicity in children: Basic mechanisms and clinical correlates, Brain, 126 (2003) 5.
28. Zawia N H & Basha M R, Environmental risk factors and the developmental basis for Alzheimer's disease, Rev Neurosci, 16 (2005) 325.
29. Bolin C M, Basha R, Cox D, Zawia N H, Maloney B & Lahiri D K, Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain, FASEB J, 20 (2006)788.
30. Wu J, Basha M R, Brock B, Maloney B, Cox D & Harry J, Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): Evidence for a developmental origin and environmental link for AD, J Neurosci, 28 (2008) 3.
31. Selkoe D J, Alzheimer's disease: Genes, proteins, and therapy, Physiol Rev, 81 (2001) 741.
32. Nishimura I, Uetsuki T, Kuwako K, Hara T, Kawakami T, Aimoto S & Yoshikawa K, Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein, Cell Death Differ, 9 (2002) 199.
33. Lahiri D K, Farlow M R, Sambamurti K, Greig N H, Giacobini E & Schneider L S, A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease, Curr Drug Targets, 4 (2003) 97.
34. Zawia N H, Sharan R, Brydie M, Oyama T & Crumpton T, SP1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression, Brain Res Dev Brain Re, 107 (1998) 291.
35. Gatz J L, Tyas S L, Philip St. J & Montgomery P, Do Depressive Symptoms Predict Alzheimer's Disease and Dementia? The J Gerontol Series A: Biol Sci and Med Sci, 60 (2005) 744.
36. Raiha I, Kaprio J, Koskenvuo M, Rajala T & Sourander L, Alzheimer's disease in twins (Review) Biomed Pharmacother, 51 (1997) 101.
37. Lu T, Pan Y, Kao S Y, Li C, Kohane I, Chan J & Yankner B A, Gene regulation and DNA damage in the ageing human brain, Nature, 429 (2004) 883.
38. Pokier L A & Vlasova T I, The prospective role of abnormal methyl metabolism in cadmium toxicity, Environ Health Perspect, 10(2002)793.
39. Takiguchi M, Achanzar W E, Qu W, Li G & Waalkes M P, Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation, Exp Cell Res, 286 (2003) 355.
40. Zawia N H, Lahiri D K & Cardozo-Pelaez F, Epigenetics, oxidative stress, and Alzheimer disease, Free Radic Biol Med, 46 (2009)1241.